The global ET catheter ablation market size is expected to be worth around US$ 3.4 bn by the end of 2030 with a CAGR of 7.9% during the forecast period of 2021 to 2030.
The healthcare sector is forever evolving and readily embraces new technologies that are proven efficient at providing cure to the community. Minimally invasive procedures have been very well received by the medical practitioners and its application has escalated in the recent past, providing a traction to the EP catheter ablation market.
Unwavering prevalence of cardiac conditions such as flutter, atrial fibrillation, and arrhythmia has driven the adoption of medical procedures such as ablation and electrophysiology (EP) study. Utilization of EP ablation catheters in treatment of cardiovascular disorders continues to gain significant traction. Patients are being drawn towards reliable procedures such as electrophysiology study for the heart. The success rate of these procedures promotes the reputation of catheters being used. Transparency Market Research projects that positive patient attitudes towards the utilization of catheters in ablation procedures and EP studies will foster the growth of the global EP catheter ablation market.
Prevalence of Cardiovascular Diseases Driving Demand
Prevalence of cardiovascular diseases as a result of escalating percentage of geriatrics in the global population, growing awareness regarding the reliability of electrophysiology procedures, increasing adoption of minimally invasive procedures, government support to promote the usage of new technologies, and improving healthcare infrastructure in a number of emerging economies are some of the key factors augmenting the demand in the global EP catheter ablation market.
RF Ablation Catheters to Remain in Great Demand through 2020
According to the report, the catheters to be sold in the global EP catheter ablation market by 2026-end will bring in over US$ 2.74 Bn in global revenues. Among these, the report has analyzed that sales of radiofrequency (RF) ablation catheters will be predominant. While the global market for EP catheter ablation will expand at a 7.9% CAGR during the forecast period, 2017-2026, the sales of RF ablation catheters are poised to register growth at 7% CAGR. Throughout the forecast period, over US$ 100 Mn worth of RF ablation catheters are poised to be sold annually across the globe.
Increasing Use of Ablation Catheters in Treatment of Atrial Fibrillation at Hospitals
Key insights developed in the study reveal that hospitals will be the largest end-user in the global market for EP catheter ablation. By 2026, nearly four-fifth of revenues being procured in the global EP catheter ablation market will be accounted by the end-use of these catheters in hospitals. Since the ablation and electrophysiology procedures require extended hospitalization, the demand for EP catheters and ablation catheters will be considerably high in the global market. In addition, the report also reveals that atrial fibrillation will be the key diseases indication that will propel the growth of the global EP catheter ablation market. While the use of ablation catheters in cardiac arrhythmia will be considerably high, atrial fibrillation will register high revenues, amassing more than US$ 1.5 Bn by 2026-end.
North America will emerge as the largest market for EP catheter ablation
Based on the regional forecast, the demand for ablation catheters and EP catheters is estimated to be the highest in the US and Canada, compared to other parts of the world. Prevalence of cardiovascular diseases and robust healthcare infrastructure will continue to support the growth of the EP catheter ablation market in the North America region. Over the forecast period, North America’s EP catheter ablation market will expand vigorously, registering a value CAGR of 6.7%. Europe will also be at the forefront of global EP catheter ablation market expansion as the second-most leading market. The EP catheter ablation market in the Asia-Pacific excluding Japan (APEJ) region, on the other hand, will register a steady growth on the account of growing geriatric population and manufacturing feasibilities.
Leading Manufacturers of Ablation Catheters
The report has profiled leading manufacturers of ablation catheters to assess the competition landscape of the global EP catheter ablation market. Companies such as Medtronic Plc., Boston Scientific Corporation, Johnson & Johnson, BIOTRONIK SE & Co. KG, Abbott Laboratories Inc., Lepu Medical Tech Co. Ltd., MicroPort Scientific Corporation, CardioFocus Inc., and Hansen Medical, Inc. are expected to actively partake in the expansion of the global EP catheter ablation market through 2026. Several manufacturers of ablation catheters are likely to focus on product development that aids patient comfort during the ablation procedure and EP studies.
Rising Incidence of Heart Issues to Propel Growth of EP Catheter Ablation Market
The surging prevalence of cardiac issues, coupled with the advent of advanced therapeutics worldwide is likely to help boost the global ET catheter ablation market in the near future. Unfaltering predominance of cardiovascular conditions, for example, shudder, atrial fibrillation, and arrhythmia has driven the selection of operations, for example, removal and electrophysiology (EP) study. Usage of EP removal catheters in treatment of cardiovascular issues keeps on acquiring huge footing. Patients are being drawn towards solid systems, for example, electrophysiology concentrate for the heart. The achievement pace of these strategies advances the standing of catheters being utilized. Besides, the positive patient perspectives towards the use of catheters in removal methods and EP studies will encourage the development of the worldwide EP catheter removal market.
As per segmentation by end product, the global EP catheter ablation market is dominated by hospitals segment on account of the increasing preference for treatment in hospital setup. Regionwise, the market for EP catheter ablation is expected to witness the dominance of North America. This is owing to the high prevalence of cardiovascular diseases in the well developed nations such as Canada and the United States.
Predominance of cardiovascular infections because of raising level of geriatrics in the worldwide populace, developing mindfulness with respect to the dependability of electrophysiology methods, expanding reception of negligibly intrusive methodology, government backing to advance the utilization of new innovations, and improving medical services foundation in various arising economies are a portion of the key variables increasing the interest in the worldwide EP catheter removal market.
Medtronic Plc., CardioFocus Inc., Abbott Laboratories Inc., MicroPort Scientific Corporation, BIOTRONIK SE and Co. KG, Johnson and Johnson, Lepu Medical Tech Co. Ltd., Boston Scientific Corporation, and Hansen Medical, Inc. are some players of this market.
Key Segments of the EP Catheter Ablation Market
In an exclusive report, Transparency Market Research has compiled a range of sections analyzing the expansion of the global EP catheter ablation market for the assessment period, 2017-2030. The study delivers insightful forecast on how the demand for EP catheters and ablation catheters will expand in the near future. From regional to local, the report covers the expanse of the EP catheter ablation market across global perimeters. The study has profiled leading manufacturers of medical devices to identify the top players in EP catheter and ablation catheter manufacturing. Company profiles in this report provide a greater understanding on the developments of each players, and reveals the hidden motive behind their recent strategies. The report serves as a reliable business document that can enable market participants in developing new strategies towards future market direction.
The report is equipped with first-hand information derived from direct interviews and procurement of statistics from authentic databases. Key features of the report include a segmental analysis of the global EP catheter ablation market, and competition snapshot. An overview of the parent industry for medical devices has been provided in the report. The report further delivers a standard introduction to the global EP catheter ablation market and provides definition on the catheters used in the procedures.
Analysis on supply chain, medical regulations, cost structure, and product life cycle has been provided in the report. Information on latest as well as pending patents has been offered in the report. From the list of distributors to recent mergers and acquisitions, the report has analyzed multiple aspects encircling the sales of EP catheters and ablation catheters. Moreover, distinct sections on PESTLE analysis and competitive footprint are also compiled in the study. The report further reveals an intensity map that traces the presence of each market participant across the regions and sub-regions.
A slew of research methods have been employed in the development of this report. The study remains unbiased with its information and doesn’t intend to promote individual entities through inferences that reveal high value statistics. In fact, such inferences are the USPs of the report as they can be redirected towards business development of market participants. The report has infused quantitative estimations and qualitative insights, and has been developed by considering metrics such as absolute dollar opportunities, compounded annual growth rates (CAGR) and Year-on-Year (Y-o-Y) growth rates for interpreting the market size estimations. To capture universal understanding, the estimations and evaluations in the report have been quantified in US dollars (US$). The scope of the report is to provide valuable information for manufacturers of EP catheters and ablation catheters. This information will enable them to make the required changes in terms of product developments, technology partnerships, and entering untapped markets.
Clinical Trial Equipment & Ancillary Solutions Market (By Product: Sourcing, Supply/Logistics, Service, Others; By Phase: Phase I, Phase II, Phase III, Phase IV) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dental Suction Systems Market (By Product: Wet Suction, Dry Suction; By End-use: Hospitals, Dental Offices) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Dental Caries Detectors Market (By Product: Laser Fluorescent Caries Detector, Fiber Optic Trans-illumination Caries Detector; By End-use: Hospitals, Dental Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Ophthalmic Perimeters Market (By Product: Static, Kinetic, Combination; By End-use: Hospital, Ophthalmic Clinic, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...
Investigational New Drug CDMO Market (By Product: Small Molecule, Large Molecule; By Service: Contract Development, Contract Manufacturing; By End-use: Pharmaceutical Companies, Biotech Companies, Others (Government, Research Institutes, Academic Institutes, etc.)) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030Read more...